Published in Immunol Rev on June 01, 2001
Natural selection drives recurrent formation of activating killer cell immunoglobulin-like receptor and Ly49 from inhibitory homologues. J Exp Med (2005) 2.23
Natural killer cell biology: an update and future directions. J Allergy Clin Immunol (2013) 1.56
KIR-HLA intercourse in HIV disease. Trends Microbiol (2008) 1.55
Cis interactions of immunoreceptors with MHC and non-MHC ligands. Nat Rev Immunol (2008) 1.50
Reduction of GVHD and enhanced antitumor effects after adoptive infusion of alloreactive Ly49-mismatched NK cells from MHC-matched donors. Blood (2006) 1.27
The immune gene repertoire of an important viral reservoir, the Australian black flying fox. BMC Genomics (2012) 1.13
Chimpanzees use more varied receptors and ligands than humans for inhibitory killer cell Ig-like receptor recognition of the MHC-C1 and MHC-C2 epitopes. J Immunol (2009) 1.12
The natural killer complex regulates severe malarial pathogenesis and influences acquired immune responses to Plasmodium berghei ANKA. Infect Immun (2005) 1.07
Mouse NK cell-mediated rejection of bone marrow allografts exhibits patterns consistent with Ly49 subset licensing. Blood (2011) 1.01
Structural basis for recognition of MHC and MHC-like ligands by natural killer cell receptors. Semin Immunol (2006) 0.99
Molecular architecture of the major histocompatibility complex class I-binding site of Ly49 natural killer cell receptors. J Biol Chem (2008) 0.99
Evolution and survival of marine carnivores did not require a diversity of killer cell Ig-like receptors or Ly49 NK cell receptors. J Immunol (2009) 0.98
Cutting edge: MHC class I-Ly49 interaction regulates neuronal function. J Immunol (2008) 0.97
Structural basis for recognition of cellular and viral ligands by NK cell receptors. Front Immunol (2014) 0.94
Inhibitory C-type lectin receptors in myeloid cells. Immunol Lett (2010) 0.94
DAP10 associates with Ly49 receptors but contributes minimally to their expression and function in vivo. Eur J Immunol (2009) 0.93
Targeting of a natural killer cell receptor family by a viral immunoevasin. Nat Immunol (2013) 0.86
Antigen-specific expansion and differentiation of natural killer cells by alloantigen stimulation. J Exp Med (2014) 0.86
Neurons preferentially respond to self-MHC class I allele products regardless of peptide presented. J Immunol (2009) 0.86
Expression of murine killer immunoglobulin-like receptor KIRL1 on CD1d-independent NK1.1(+) T cells. Immunogenetics (2007) 0.83
Identification of a KIR antisense lncRNA expressed by progenitor cells. Genes Immun (2013) 0.83
Characterization of a weakly expressed KIR2DL1 variant reveals a novel upstream promoter that controls KIR expression. Genes Immun (2014) 0.83
The evolution of the natural killer complex; a comparison between mammals using new high-quality genome assemblies and targeted annotation. Immunogenetics (2017) 0.80
Bone marrow allograft rejection mediated by a novel murine NK receptor, NKG2I. J Exp Med (2004) 0.77
Characterization of KIR intermediate promoters reveals four promoter types associated with distinct expression patterns of KIR subtypes. Genes Immun (2015) 0.77
Regulation of natural killer cell function: a role for the NK cell's own MHC class I molecules. Med Microbiol Immunol (2005) 0.75
Identification and Analysis of Natural Killer Cells in Murine Nasal Passages. PLoS One (2015) 0.75
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science (1992) 5.94
Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med (1981) 5.76
Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med (1993) 4.94
Natural killer cells: their roles in defenses against disease. Science (1981) 4.59
Interaction of IL-2R beta and gamma c chains with Jak1 and Jak3: implications for XSCID and XCID. Science (1994) 3.46
Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature (1994) 3.31
Natural killer cells: characteristics and regulation of activity. Immunol Rev (1979) 3.14
Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J Immunol (1984) 3.07
Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol (1981) 3.05
Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature (1979) 2.94
Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP. Proc Natl Acad Sci U S A (2000) 2.80
Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med (1986) 2.70
Heterogeneity of natural killer cells. Annu Rev Immunol (1984) 2.59
Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol (1995) 2.52
Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A (1995) 2.52
Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A (1995) 2.19
DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem (1998) 2.10
Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol (1986) 2.05
Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol (1977) 1.88
Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A (1994) 1.84
Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med (1995) 1.78
Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol (1986) 1.72
Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol (1996) 1.70
Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol (2001) 1.63
In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol (2000) 1.57
Activation of human peripheral blood T lymphocytes by pharmacological induction of protein-tyrosine phosphorylation. Proc Natl Acad Sci U S A (1992) 1.55
Identification of RANTES receptors on human monocytic cells: competition for binding and desensitization by homologous chemotactic cytokines. J Exp Med (1993) 1.53
Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. J Immunol (1981) 1.51
One-signal requirement for interferon-gamma production by human large granular lymphocytes. J Immunol (1987) 1.49
Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII). J Immunol (1991) 1.48
Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med (1984) 1.41
Tec family kinases modulate thresholds for thymocyte development and selection. J Exp Med (2000) 1.41
Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. J Immunol (1985) 1.40
Mediation of mouse natural cytotoxic activity by tumour necrosis factor. Nature (1986) 1.39
Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain. Proc Natl Acad Sci U S A (1991) 1.39
The Ly-49D receptor activates murine natural killer cells. J Exp Med (1996) 1.39
Isolation of human and rat natural killer cells. J Immunol Methods (1982) 1.39
Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. J Immunol (1986) 1.37
Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol (1999) 1.37
Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J Natl Cancer Inst (1977) 1.36
Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2) J Exp Med (1995) 1.35
Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity. J Immunol (1982) 1.34
IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor. J Immunol (1989) 1.33
Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity. J Immunol (1979) 1.32
Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood (2000) 1.31
Selective depletion of human natural killer cells on monolayers of target cells. J Immunol (1980) 1.29
Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med (1999) 1.27
The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol (1996) 1.26
A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A (1984) 1.23
Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. J Exp Med (1990) 1.22
Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med (1990) 1.19
Human large granular lymphocytes are potent producers of interleukin-1. Nature (1984) 1.18
IL-8 gene expression and production in human peripheral blood lymphocyte subsets. J Immunol (1991) 1.18
A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci U S A (1993) 1.17
Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol (1991) 1.17
Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol (1987) 1.17
A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J Immunol (1992) 1.17
Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol (1985) 1.17
Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol (2001) 1.15
Transformation of owl monkey T cells in vitro with Herpesvirus saimiri. Proc Natl Acad Sci U S A (1984) 1.14
Analysis of T cell receptors in highly purified rat and human large granular lymphocytes (LGL): lack of functional 1.3 kb beta-chain mRNA. J Immunol (1986) 1.14
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 1.14
Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity. J Immunol (1980) 1.12
Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int J Cancer (1983) 1.12
Monocyte chemotactic protein-3 (MCP3) interacts with multiple leukocyte receptors: binding and signaling of MCP3 through shared as well as unique receptors on monocytes and neutrophils. Eur J Immunol (1995) 1.12
NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol (1996) 1.09
IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol (1990) 1.09
Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol (1999) 1.09
Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J Leukoc Biol (1995) 1.09
Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol (1982) 1.08
Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol (1999) 1.08
Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity. Blood (1980) 1.08
IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol (1999) 1.07
Role of a STAT binding site in the regulation of the human perforin promoter. J Immunol (1999) 1.07
Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol (1998) 1.06
The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol (1999) 1.05
The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc Natl Acad Sci U S A (1999) 1.05
Characteristics of human NK clones: target specificity and phenotype. J Immunol (1984) 1.03
Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol (1998) 1.02
Characterization of a silencer regulatory element in the human interferon-gamma promoter. J Biol Chem (1994) 1.02
Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J Immunol (1989) 1.02
Thrombopoietin induces tyrosine phosphorylation and activation of the Janus kinase, JAK2. Blood (1995) 1.01
Intralesional infusion of lymphokine-activated killer (LAK) cells and recombinant interleukin-2 (rIL-2) for the treatment of patients with malignant brain tumor. Neurosurgery (1988) 0.99
Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes. Cancer Res (1991) 0.98
Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis. Am J Pathol (1997) 0.98
Cultures of purified human natural killer cells: growth in the presence of interleukin 2. Cell Immunol (1982) 0.98
Modulation of fetal antigen(s) in mouse leukemia cells. Cancer Res (1974) 0.98
Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J Immunol (1983) 0.97
Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion. J Immunol (2000) 0.97
Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J Immunol (1993) 0.97
Functional association of FcepsilonRIgamma with arginine(632) of paired immunoglobulin-like receptor (PIR)-A3 in murine macrophages. Blood (1999) 0.97
Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J Immunol (1998) 0.96
Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells. J Immunol (2001) 0.96